Recent studies suggest that surgical exposure of the sciatic nerve prior to assessment of nerve blood flow (NBF) may account for discordant reports of increased versus decreased NBF in diabetic and galactosemic rats. Regardless of whether NBF is observed to be increased or decreased, it is normalized by inhibitors of aldose reductase (ARI). To clarify these paradoxical findings, NBF was examined in rats (7-8 rats per group) fed normal chow (C), chow containing 50% galactose (G), or 50% galactose + the ARI zopolrestat (Z) at 100 mg/kg/day. After 3 weeks the rats were anesthetized and one sciatic nerve was surgically exposed (SE) without touching the nerve. The incision was immediately closed and 2 h later NBF (ml/g wet wt/min) was assessed in the SE nerve and in the contralateral unexposed nerve (UE) by injection o 10 um 46Sc-microspheres. In UE nerves NBF was 37% higher in G than in C. This increase was prevented by Z. In SE nerves NBF was 49% lower in G than in C and was virtually normalized by Z. These data indicate that 1) galactosemia increases NBF by 37% in UE nerves, 2) SE markedly increases NBF by 4 fold in C rats but only 1.5 fold in G rats, and 3) the reduced NBF in SE nerves in G vs C are largely prevented by ARI. These observations are consistent with numerous reports that vasodilatory responses to various stimuli are blunted by aldose reductase-linked mechanisms in diabetic rats. These observations provide an explantation for most previous discordant reports of increased versus decreased sciatic NBF induced by galactosemia and diabetes.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR000954-20
Application #
5221879
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Yue, Xuyi; Dhavale, Dhruva D; Li, Junfeng et al. (2018) Design, synthesis, and in vitro evaluation of quinolinyl analogues for ?-synuclein aggregation. Bioorg Med Chem Lett 28:1011-1019
Ohlemacher, Shannon I; Giblin, Daryl E; d'Avignon, D André et al. (2017) Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria. J Clin Invest 127:4018-4030
Lin, Xiaobo; Racette, Susan B; Ma, Lina et al. (2017) Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans. Arterioscler Thromb Vasc Biol 37:2364-2369
Ovod, Vitaliy; Ramsey, Kara N; Mawuenyega, Kwasi G et al. (2017) Amyloid ? concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement 13:841-849
Cade, W Todd; Levy, Philip T; Tinius, Rachel A et al. (2017) Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes. Pediatr Res 82:768-775
Lucey, Brendan P; Mawuenyega, Kwasi G; Patterson, Bruce W et al. (2017) Associations Between ?-Amyloid Kinetics and the ?-Amyloid Diurnal Pattern in the Central Nervous System. JAMA Neurol 74:207-215
Hölttä, Mikko; Dean, Robert A; Siemers, Eric et al. (2016) A single dose of the ?-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Alzheimers Res Ther 8:11
Karner, Courtney M; Esen, Emel; Chen, Jiakun et al. (2016) Wnt Protein Signaling Reduces Nuclear Acetyl-CoA Levels to Suppress Gene Expression during Osteoblast Differentiation. J Biol Chem 291:13028-39
Alvarez, Jessica A; Ziegler, Thomas R; Millson, Erin C et al. (2016) Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity. Nutrition 32:447-52
Sterl, Karin; Wang, Songyan; Oestricker, Lauren et al. (2016) Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery. Peptides 82:76-84

Showing the most recent 10 out of 696 publications